Quantum 8-K Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009

EXHIBIT 99.1

                

                   healthcare solutions for a new generation^SM

3420 Fairlane Farms Road, Suite C¨  Wellington, Florida  33414  ¨   561.798.9800 (office)  ¨   561.296.3456 (fax)

­

The Quantum Group Completes Corporate Expansion Plan;

Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009

WELLINGTON, Fla. (May 21, 2008) - The Quantum Group, Inc. (AMEX:QGP, QGP.WSA, QGP.WSB) (www.QuantumMD.com)announced today that it has successfully completed a corporate expansion plan.  The Company increased its employment base by 23% since January 2008, expanded its office facility size from 6,600 sq. ft. to 10,600 sq. ft., and has moved a branch office from southwest Miami to a larger facility in Doral (west Miami), Florida.

Susan Darby Guillama, Executive Vice President and Chief Administrative Officer stated, “The expansion of our facilities has been much anticipated and was delayed until the completion of our public offering in December of 2007. Our increased headcount and corporate footprint significantly strengthens our ability to service our nearly 2,000 contracted providers, our numerous HMO partners and the nearly 2,500 [patient] members.  With an expanded infrastructure in place, we expect to continue to grow the size of our business during the next 12 months.”

About The Quantum Group, Inc.

The Quantum Group provides business process solutions, service chain management, strategic consulting and leading edge technology innovations to the healthcare industry.

Through our dynamic patient-centric architecture, we empower the communication that is critical for the coordination of care and take aim at the $600 billion inefficiency gap in the United States healthcare industry. We are guided by a mission to develop efficiencies, improve the quality of patient care and achieve cost reductions for the nation’s largest and fastest growing industry.  

We have developed leading-edge technology with the creation and deployment of a series of innovative patent-pending initiatives.  Through nearly 2,000 healthcare providers and

multiple insurance company relationships under management, we are positioned to be a catalyst for change to the Florida healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company’s Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as “expects,” “plans,” “will,” “may,” “anticipates,” “believes,” “should,” “intends,” “estimates” and other words of similar meaning.  These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual resul ts may differ materially from those expressed or implied by these forward-looking statements.  Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well physician clients.  The Company does not undertake any obligation to publicly update any forward-looking statements.  There can be no assurance that the provisional patents discussed in this press release will be granted by the US Patent and Trademark Office, or, if they are granted, they will not be challenged by third parties, or if not that we will be able to effectively use or commercialize such patents and/or we may not have the resources to deploy such technology. As a result, investors should not place undue reliance on these forward-looking statements.

FOR MORE INFORMATION, PLEASE CONTACT:

PR Financial Marketing

Jim Blackman: 713-256-0369

jim@prfmonline.com

or

Danielle Amodio

Vice President Corporate Communications

The Quantum Group, Inc.

561.798.9800